Home World News EMA Recommends Extension of Indications for Inotuzumab Ozogamicin World News EMA Recommends Extension of Indications for Inotuzumab Ozogamicin By Ogkologos - April 29, 2026 219 0 Facebook Twitter Google+ Pinterest WhatsApp New indication concerns treatment of paediatric patients with CD22-positive B cell precursor ALL Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR FDA Proposes Rule Prohibiting Menthol Cigarettes June 27, 2022 41-Year-Old Wrinkled Woman Who Ages 8 Times Faster Than Normal Is... March 14, 2019 EMA Recommends Granting a Marketing Authorisation for Germanium (68Ge) chloride /... June 28, 2024 Machine Learning-Based Model Shows Promise for Indicating Response to Immune Checkpoint... December 9, 2020 Load more HOT NEWS New Study Says At-Home Cancer Care May Lead to Fewer Hospitalizations... Expressive Writing, What is It? EMA Recommends Extension of Therapeutic Indications for Rucaparib Bus Driver Finds Out Teen With Cancer Can’t Afford Prom &...
